Breaking News on Global Pharmaceutical Technology & Manufacturing

Headlines > September 2005

« Previous month Next month »

Study suggests weakening HIV virus

30-Sep-2005 - According to new study, the virus that causes AIDS is becoming more sensitive to drug treatments, contradicting a wealth of research that demonstrates the emergence of drug resistant viral strains.

Researcher's new receptor advances drug discovery process

30-Sep-2005 - US scientists have designed a new receptor and enhanced bioassay that is set to advance the drug discovery process for diseases such as cystic fibrosis and Bartter's syndrome, tracking a...

Analysts predict improved microarray market performance

29-Sep-2005 - According to a recent report, the emerging market for protein microarrays will experience strong growth buoyed on by the emergence of the technology's ability to detect protein expression more quickly...

Phoqus plans to raise £10-£12m via AIM listing

29-Sep-2005 - UK drug delivery company Phoqus has said it plans to list on the Alternative Investment Market (AIM) via an institutional placing that should raise proceeds of £10-£12 million.

Dutch CMO hikes production capacity

29-Sep-2005 - Contract biopharmaceutical manufacturer SynCo Bio Partners has started construction of two new manufacturing suites at its facility in Amsterdam, the Netherlands, in a move that builds on the firm's ability...

India's Matrix Labs continues down acquisition trial

29-Sep-2005 - India's Matrix Laboratories has made two acquisitions that will enhance its presence in the European and Asian markets for pharmaceutical intermediates and active pharmaceutical ingredients (APIs).

Portable labs detect water toxins faster

29-Sep-2005 - Two novel technologies, designed to check water supplies for toxins, is set to provide a new on-site monitoring approach, enhancing current utility monitoring systems that require water samples to be...

Superfos closes UK pharma packaging plant

29-Sep-2005 - Danish packaging company Superfos has continued the refocusing of its pharmaceuticals business with the closure of a UK plant that the company has deemed too small to operate efficiently.

Animal activists target children's nurseries

29-Sep-2005 - Animal activists' latest target in its campaign of terrorism has centred on a chain of children's nurseries that has links with the chemicals testing company, Huntingdon Life Sciences (HLS).

People on the move

28-Sep-2005 - In-PharmaTechnologist.com reports its periodic round-up of personnel changes in pharmaceutical manufacturing and development.

UK firm unveils first non-toxic biocide

28-Sep-2005 - Greenbridge Environmental Control of the UK has introdueced a new cleaner and disinfectant agent, suitable for commercial scale applications, that is claimed to be the first non-toxic product of its...

SkyePharma rights issue weighs on share price

28-Sep-2005 - UK drug delivery company Skyepharma has been forced to raise funds to carry out trials of its combination drug for asthma and chronic obstructive pulmonary disease (COPD) after failing to...

Celtic Pharma declares Transfersome carrier interest

28-Sep-2005 - Celtic Pharma has announced the acquisition of a stake in IDEA - a biopharma company, which is developing targeted therapeutics based on novel, Transfersome carriers that can increase drug potency...

Patent on low-cost safety syringe filed

28-Sep-2005 - A patent covering a simple design for a safety syringe, which uses a vacuum rather than a spring to retract the needle after use and should be cheaper to manufacture...

Advanced Biosciences takes sales into own hands

27-Sep-2005 - The Advanced Biosciences division of US specialty materials maker Rohm and Haas has decided to sell its entire range of solutions for the production of biopharmaceuticals directly to customers.

Genzyme unveils $540m expansion plan for manufacturing, R&D

27-Sep-2005 - US biotechnology major Genzyme officially opened four European facilities last week as part of a investment package eventually expected to cost $540 million (€449m).

In-bottle oxygen absorber launched by Multisorb

27-Sep-2005 - Multisorb Technologies has launched a new oxygen-absorbing product to increase the shelf life of pharmaceuticals at the ongoing Pack Expo Las Vegas exhibition.

Pliva secures new contract to make azithromycin

27-Sep-2005 - Croatian pharmaceutical company Pliva has signed a new three-year agreement with Pfizer for the bulk supply of azithromycin, the active ingredient in the antibacterial drug Zithromax.

New lab system allows macromolecule analysis

27-Sep-2005 - PANalytical has added a new focusing mirror to its range of PreFIX optics that for the first time, can analyse macromolecules using a standard, laboratory-based XRD system, rather than on...

DecisionNews Media seeks pharma industry reporter

27-Sep-2005 - DecisionNews Media is seeking a further reporter for its pharmaceuticals industry news services. Applicants must be exceptionally bright, ambitious and talented, with experience in news writing on the pharmaceuticals industry.

Solubilising excipient gets green light in Japan

26-Sep-2005 - Eastman Chemical Co's Vitamin E TPGS has been approved as a pharmaceutical excipient for oral drug formulations in Japan by the Japanese government's Ministry of Health, Labour and Welfare.

Gerresheimer expands in US and China with GGI purchase

26-Sep-2005 - German packaging company Gerresheimer has announced plans to take over the pharmaceutical business of troubled Glass Group Inc (GGI) of the US, after a Delaware bankruptcy court approved the transaction.

Researchers add piece to cancer drug resistance

26-Sep-2005 - Researchers in the US have uncovered a contributing factor in interferon resistance of malignant melanoma cells. The finding represents a step forward in understanding of this type of cancer and...

Locostatins identified as cancer drug targets

26-Sep-2005 - A newly discovered compound, which has revealed new links between cell signalling pathways and cell migration, may suggest new avenues for novel pharmaceutical therapies for treating a variety of diseases,...

Genentech halts Avastin drug study

26-Sep-2005 - Genentech has announced that studies of Avastin in platinum-refractory ovarian cancer patients have been discontinued due to patients developing a serious bowel problem.

« Previous month Next month »

Key Industry Events

 

Access all events listing

Our events, Events from partners...